<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Machine Learning-Based Prediction of ICU Admission in Febrile Oncology Patients</title>
    <style>
        :root {
            --primary-color: #1a365d;
            --secondary-color: #2c5282;
            --accent-color: #3182ce;
            --text-color: #2d3748;
            --bg-color: #f7fafc;
            --card-bg: #ffffff;
            --border-color: #e2e8f0;
            --success-color: #38a169;
            --warning-color: #d69e2e;
        }

        * {
            margin: 0;
            padding: 0;
            box-sizing: border-box;
        }

        body {
            font-family: 'Segoe UI', 'Helvetica Neue', Arial, sans-serif;
            line-height: 1.7;
            color: var(--text-color);
            background: var(--bg-color);
            font-size: 16px;
        }

        .paper-container {
            max-width: 900px;
            margin: 0 auto;
            padding: 40px 20px;
        }

        header {
            text-align: center;
            padding: 40px;
            background: linear-gradient(135deg, var(--primary-color), var(--secondary-color));
            color: white;
            border-radius: 12px;
            margin-bottom: 40px;
            box-shadow: 0 10px 40px rgba(26, 54, 93, 0.2);
        }

        header h1 {
            font-size: 1.8rem;
            font-weight: 700;
            margin-bottom: 20px;
            line-height: 1.3;
        }

        .authors {
            font-size: 1rem;
            opacity: 0.95;
            line-height: 1.8;
        }

        .authors strong {
            color: #90cdf4;
        }

        .primary-author {
            font-size: 1.2rem;
            font-weight: 600;
            margin-bottom: 10px;
            color: #bee3f8;
        }

        section {
            background: var(--card-bg);
            padding: 30px 40px;
            margin-bottom: 20px;
            border-radius: 8px;
            box-shadow: 0 2px 10px rgba(0, 0, 0, 0.05);
        }

        h2 {
            color: var(--primary-color);
            font-size: 1.5rem;
            margin-bottom: 20px;
            padding-bottom: 10px;
            border-bottom: 3px solid var(--accent-color);
        }

        h3 {
            color: var(--secondary-color);
            font-size: 1.2rem;
            margin: 25px 0 15px 0;
        }

        h4 {
            color: var(--text-color);
            font-size: 1.05rem;
            margin: 20px 0 10px 0;
        }

        p {
            margin-bottom: 15px;
        }

        .abstract {
            background: linear-gradient(to bottom, #ebf8ff, #ffffff);
            border-left: 4px solid var(--accent-color);
        }

        .abstract p strong {
            color: var(--primary-color);
        }

        .keywords {
            margin-top: 20px;
            padding: 15px;
            background: #edf2f7;
            border-radius: 6px;
            font-size: 0.9rem;
        }

        table {
            width: 100%;
            border-collapse: collapse;
            margin: 20px 0;
            font-size: 0.9rem;
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.05);
            page-break-inside: avoid;
            break-inside: avoid;
        }

        th,
        td {
            padding: 12px 15px;
            text-align: left;
            border-bottom: 1px solid var(--border-color);
        }

        th {
            background: var(--primary-color);
            color: white;
            font-weight: 600;
            text-transform: uppercase;
            font-size: 0.8rem;
        }

        tr:hover {
            background: #f8fafc;
        }

        tr.highlight {
            background: #ebf8ff;
            font-weight: 600;
        }

        .figure-container {
            margin: 30px 0;
            text-align: center;
            page-break-inside: avoid;
            break-inside: avoid;
        }

        .figure-container img {
            max-width: 100%;
            height: auto;
            border-radius: 8px;
            box-shadow: 0 4px 15px rgba(0, 0, 0, 0.1);
        }

        .figure-caption {
            margin-top: 15px;
            font-size: 0.95rem;
            color: #4a5568;
            font-style: italic;
        }

        .figure-caption strong {
            color: var(--primary-color);
            font-style: normal;
        }

        .metrics-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(200px, 1fr));
            gap: 20px;
            margin: 25px 0;
        }

        .metric-card {
            text-align: center;
            padding: 20px;
            background: linear-gradient(135deg, #ebf8ff, #ffffff);
            border-radius: 10px;
            box-shadow: 0 2px 10px rgba(0, 0, 0, 0.05);
            border: 1px solid #bee3f8;
        }

        .metric-value {
            font-size: 2rem;
            font-weight: 700;
            color: var(--accent-color);
        }

        .metric-label {
            font-size: 0.85rem;
            color: #4a5568;
            margin-top: 5px;
            text-transform: uppercase;
        }

        .metric-ci {
            font-size: 0.8rem;
            color: #718096;
            margin-top: 3px;
        }

        ul,
        ol {
            margin: 15px 0 15px 25px;
        }

        li {
            margin-bottom: 8px;
        }

        .highlight-box {
            background: linear-gradient(to right, #f0fff4, #ffffff);
            border-left: 4px solid var(--success-color);
            padding: 20px;
            margin: 20px 0;
            border-radius: 0 8px 8px 0;
        }

        .caution-box {
            background: linear-gradient(to right, #fffaf0, #ffffff);
            border-left: 4px solid #ed8936;
            padding: 15px 20px;
            margin: 20px 0;
            border-radius: 0 8px 8px 0;
            font-size: 0.95rem;
        }

        .references {
            font-size: 0.9rem;
        }

        .references ol {
            padding-left: 20px;
        }

        .references li {
            margin-bottom: 12px;
            padding-left: 5px;
        }

        .two-column {
            display: grid;
            grid-template-columns: 1fr 1fr;
            gap: 30px;
        }

        @media (max-width: 768px) {
            .two-column {
                grid-template-columns: 1fr;
            }

            section {
                padding: 20px;
            }

            header h1 {
                font-size: 1.4rem;
            }
        }

        footer {
            text-align: center;
            padding: 30px;
            color: #718096;
            font-size: 0.85rem;
        }

        /* Print styles - force background colors to print */
        @media print {
            * {
                -webkit-print-color-adjust: exact !important;
                print-color-adjust: exact !important;
                color-adjust: exact !important;
            }

            body {
                background: white;
            }

            header {
                background: #1a365d !important;
                color: white !important;
                -webkit-print-color-adjust: exact !important;
                print-color-adjust: exact !important;
            }

            header h1 {
                color: white !important;
            }

            .paper-container {
                max-width: 100%;
                padding: 0;
            }

            section {
                box-shadow: none;
                border: 1px solid #e2e8f0;
            }
        }
    </style>
</head>

<body>
    <div class="paper-container">
        <header>
            <h1>Machine Learning-Based Prediction of ICU Admission in Febrile Oncology Patients</h1>
            <div style="margin-top: 25px; padding-top: 20px; border-top: 1px solid rgba(255,255,255,0.3);">
                <p style="font-size: 1.3rem; font-weight: 500; letter-spacing: 0.5px;">by <strong>Aditya Iyer</strong>
                </p>
            </div>
        </header>

        <section class="acknowledgements"
            style="background: linear-gradient(to bottom, #faf5ff, #ffffff); border-left: 4px solid #805ad5;">
            <h2>Acknowledgements</h2>
            <p>This research was conducted under the guidance and mentorship of qualified scientists at Apollo
                Hospitals, Bangalore, India. The author gratefully acknowledges:</p>

            <div
                style="display: grid; grid-template-columns: repeat(auto-fit, minmax(300px, 1fr)); gap: 25px; margin-top: 20px;">
                <div
                    style="background: white; padding: 20px; border-radius: 8px; box-shadow: 0 2px 8px rgba(0,0,0,0.05);">
                    <h4 style="color: #553c9a; margin-bottom: 10px;">Dr. Vishwanath Sathyanarayanan</h4>
                    <p style="font-size: 0.85rem; color: #718096; margin-bottom: 8px;">MBBS, MD (Internal Medicine), DM
                        (Medical Oncology)</p>
                    <p style="margin: 0; font-size: 0.9rem;"><strong>Qualified Scientist and Principal
                            Investigator</strong><br>
                        Clinical Fellowship, MD Anderson Cancer Center, USA<br>
                        Lead Oncosciences, Karnataka Region<br>
                        Senior Consultant & Academic Advisor<br>
                        Department of Medical Oncology<br>
                        Apollo Hospitals, Bangalore<br>
                        <small style="color: #a0aec0;">KMC Reg. No. 70314</small>
                    </p>
                    <p style="margin-top: 12px; font-size: 0.85rem; color: #4a5568; font-style: italic;">Provided access
                        to de-identified clinical data, guidance on clinical interpretation, and oversight of research
                        methodology.</p>
                </div>
                <div
                    style="background: white; padding: 20px; border-radius: 8px; box-shadow: 0 2px 8px rgba(0,0,0,0.05);">
                    <h4 style="color: #553c9a; margin-bottom: 10px;">Dr. Narendhar Gokulanathan</h4>
                    <p style="font-size: 0.85rem; color: #718096; margin-bottom: 8px;">MBBS, MD, DrNB (Medical Oncology)
                    </p>
                    <p style="margin: 0; font-size: 0.9rem;"><strong>Research Mentor and Supervisor</strong><br>
                        Academic Registrar, Medical Oncology<br>
                        Department of Medical Oncology<br>
                        Apollo Hospitals, Bangalore</p>
                    <p style="margin-top: 12px; font-size: 0.85rem; color: #4a5568; font-style: italic;">Provided
                        mentorship, feedback on study design, and supervision throughout the research process.</p>
                </div>
            </div>

            <p style="margin-top: 20px; padding: 15px; background: #f0fff4; border-radius: 6px; font-size: 0.9rem;">
                <strong>Student Contribution:</strong> The computational analysis, model development, validation, and
                manuscript preparation were independently performed by the student author.
            </p>
        </section>

        <section class="abstract">
            <h2>Abstract</h2>
            <p><strong>Background:</strong> Febrile illness in cancer patients can range from self-limiting infections
                to life-threatening sepsis. Early identification of patients requiring ICU admission is crucial for
                appropriate triage and resource allocation.</p>

            <p><strong>Objective:</strong> To develop and validate a machine learning model for predicting ICU admission
                in oncology patients presenting with febrile illness.</p>

            <p><strong>Methods:</strong> We conducted a retrospective cohort study of 149 oncology patients. Clinical
                features including MASCC score, qSOFA, hypotension status, tumor type, neutropenia, metastatic status,
                infection focus, line of therapy, comorbidities, age, and gender were extracted. We developed an XGBoost
                classifier and compared it to logistic regression and clinical scores (MASCC, qSOFA). Performance was
                evaluated using 10×5-fold cross-validation with bootstrap confidence intervals.</p>

            <p><strong>Results:</strong> Among 149 patients, 81 (54.4%) required ICU admission. The XGBoost model
                achieved an AUROC of 0.934 (95% CI: 0.863-1.000), outperforming logistic regression (0.917), MASCC alone
                (0.656), qSOFA alone (0.838), and combined MASCC+qSOFA (0.864). The model demonstrated good calibration
                (Brier score: 0.092) and clinical utility across decision thresholds. Importantly, sensitivity analysis
                excluding hypotension (a near-deterministic ICU trigger) still achieved AUROC of 0.887, demonstrating
                the model's value beyond obvious clinical protocols.</p>

            <p><strong>Conclusions:</strong> A machine learning model incorporating routinely available clinical
                features can accurately predict ICU admission in febrile oncology patients, significantly outperforming
                established clinical scores. Even without hypotension status, the model retains clinically useful
                discrimination. Prospective validation is required before clinical implementation.</p>

            <div class="keywords">
                <strong>Keywords:</strong> machine learning, oncology, febrile neutropenia, ICU admission, clinical
                prediction model, XGBoost
            </div>
        </section>

        <section>
            <h2>Key Results</h2>
            <div class="metrics-grid">
                <div class="metric-card">
                    <div class="metric-value">0.934</div>
                    <div class="metric-label">AUROC (Full Model)</div>
                    <div class="metric-ci">95% CI: 0.863-1.000</div>
                </div>
                <div class="metric-card">
                    <div class="metric-value">0.887</div>
                    <div class="metric-label">AUROC (No Hypotension)</div>
                    <div class="metric-ci">Sensitivity Analysis</div>
                </div>
                <div class="metric-card">
                    <div class="metric-value">85.9%</div>
                    <div class="metric-label">Accuracy</div>
                    <div class="metric-ci">Cross-validated</div>
                </div>
                <div class="metric-card">
                    <div class="metric-value">0.092</div>
                    <div class="metric-label">Brier Score</div>
                    <div class="metric-ci">Good Calibration</div>
                </div>
                <div class="metric-card">
                    <div class="metric-value">87.7%</div>
                    <div class="metric-label">Sensitivity</div>
                    <div class="metric-ci">True Positive Rate</div>
                </div>
                <div class="metric-card">
                    <div class="metric-value">88.2%</div>
                    <div class="metric-label">Specificity</div>
                    <div class="metric-ci">True Negative Rate</div>
                </div>
            </div>
        </section>

        <section>
            <h2>1. Introduction</h2>
            <p>Febrile illness represents one of the most common oncological emergencies, affecting up to 80% of
                patients receiving chemotherapy for hematologic malignancies and 10-50% of those with solid tumors.
                While many febrile episodes resolve with prompt antimicrobial therapy, a subset of patients rapidly
                deteriorate and require intensive care unit (ICU) admission.</p>

            <p>Several clinical scoring systems have been developed for risk stratification. The MASCC score identifies
                low-risk patients suitable for outpatient management, while qSOFA identifies patients at risk of poor
                outcomes from sepsis. However, these scores were not specifically designed to predict ICU admission.</p>

            <p>Machine learning approaches offer the potential to capture complex relationships among clinical
                variables. In this study, we developed and validated a machine learning model to predict ICU admission
                in oncology patients presenting with febrile illness, with particular attention to whether the model
                provides value beyond obvious clinical triggers like hypotension requiring vasopressors.</p>
        </section>

        <section>
            <h2>2. Methods</h2>

            <h3>2.1 Study Design</h3>
            <p>Retrospective cohort study of 149 consecutive oncology patients presenting with febrile illness.</p>

            <h4>Inclusion Criteria:</h4>
            <ul>
                <li>Age ≥18 years</li>
                <li>Active malignancy (solid tumor or hematologic)</li>
                <li>Presentation with fever (≥38.0°C) or clinical suspicion of infection</li>
            </ul>

            <h3>2.2 Model Development</h3>
            <p><strong>Algorithm:</strong> XGBoost was selected based on its performance in clinical prediction tasks.
                Hyperparameters: 100 estimators, max depth 3, learning rate 0.1, subsample 0.8.</p>

            <h3>2.3 Validation Strategy</h3>
            <p>Repeated stratified 10×5-fold cross-validation with 1000-iteration bootstrap confidence intervals.
                Out-of-fold predictions used to prevent data leakage.</p>

            <h3>2.4 Sensitivity Analysis</h3>
            <p>To assess whether the model provides value beyond the near-deterministic relationship between
                inotrope-requiring hypotension and ICU admission, we trained a separate model excluding hypotension
                status.</p>
        </section>

        <section>
            <h2>3. Results</h2>

            <h3>3.1 Patient Characteristics</h3>
            <p>A total of 149 patients met inclusion criteria. Solid tumors comprised 69.1% of the cohort. Neutropenia
                was present in 45.6% of patients. The overall ICU admission rate was 54.4% (81/149).</p>

            <div class="highlight-box">
                <strong>Key Observation:</strong> 100% of patients with Hypotension Level 2 (requiring inotropes, n=57)
                were admitted to ICU. This reflects clinical protocol—all patients requiring vasopressor support receive
                ICU-level care.
            </div>

            <h3>3.2 Model Performance</h3>

            <div class="figure-container">
                <img src="figures/fig_roc_comparison.png" alt="ROC Curves Comparison">
                <p class="figure-caption"><strong>Figure 1.</strong> Receiver Operating Characteristic curves comparing
                    model performance.</p>
            </div>

            <table>
                <tr>
                    <th>Model</th>
                    <th>AUROC (95% CI)</th>
                    <th>AUPRC</th>
                    <th>Accuracy</th>
                    <th>Brier</th>
                </tr>
                <tr class="highlight">
                    <td><strong>XGBoost (Full)</strong></td>
                    <td><strong>0.934 (0.863-1.000)</strong></td>
                    <td><strong>0.963</strong></td>
                    <td><strong>0.859</strong></td>
                    <td><strong>0.092</strong></td>
                </tr>
                <tr class="highlight">
                    <td><strong>XGBoost (No Hypotension)</strong></td>
                    <td><strong>0.887 (0.771-0.980)</strong></td>
                    <td>0.901</td>
                    <td>0.812</td>
                    <td>0.131</td>
                </tr>
                <tr>
                    <td>Logistic Regression</td>
                    <td>0.917 (0.826-0.994)</td>
                    <td>0.947</td>
                    <td>0.851</td>
                    <td>0.113</td>
                </tr>
                <tr>
                    <td>MASCC + qSOFA</td>
                    <td>0.864 (0.767-0.932)</td>
                    <td>0.865</td>
                    <td>0.779</td>
                    <td>0.140</td>
                </tr>
                <tr>
                    <td>qSOFA Alone</td>
                    <td>0.838 (0.733-0.918)</td>
                    <td>0.840</td>
                    <td>0.710</td>
                    <td>0.152</td>
                </tr>
                <tr>
                    <td>MASCC Alone</td>
                    <td>0.656 (0.546-0.782)</td>
                    <td>0.607</td>
                    <td>0.685</td>
                    <td>0.206</td>
                </tr>
            </table>

            <h3>3.3 Feature Importance</h3>

            <div class="figure-container">
                <img src="figures/fig_feature_importance.png" alt="Feature Importance">
                <p class="figure-caption"><strong>Figure 2.</strong> XGBoost feature importance. Hypotension dominates
                    the full model; when excluded, qSOFA and metastatic status become the leading predictors.</p>
            </div>

            <div class="highlight-box">
                <strong>Sensitivity Analysis:</strong> Removing hypotension reduced AUROC from 0.934 to 0.887 — still
                clinically useful discrimination (>0.80). This demonstrates the model captures genuine predictive signal
                from other clinical features beyond the obvious hypotension-ICU relationship.
            </div>

            <h3>3.4 Calibration</h3>

            <div class="figure-container">
                <img src="figures/fig_calibration.png" alt="Calibration Curves">
                <p class="figure-caption"><strong>Figure 3.</strong> Calibration curves. The XGBoost model (slope=0.84)
                    shows reasonable calibration.</p>
            </div>

            <h3>3.5 Decision Curve Analysis</h3>

            <div class="figure-container">
                <img src="figures/fig_dca.png" alt="Decision Curve Analysis">
                <p class="figure-caption"><strong>Figure 4.</strong> Decision curve analysis. The model provides
                    positive net benefit across 10-70% threshold probabilities.</p>
            </div>

            <h3>3.6 Subgroup Analysis</h3>

            <table>
                <tr>
                    <th>Subgroup</th>
                    <th>N</th>
                    <th>ICU Events</th>
                    <th>AUROC (95% CI)</th>
                </tr>
                <tr>
                    <td>Solid Tumors</td>
                    <td>103</td>
                    <td>56</td>
                    <td>0.941 (0.890-0.983)</td>
                </tr>
                <tr>
                    <td>Hematologic</td>
                    <td>46</td>
                    <td>25</td>
                    <td>0.941 (0.851-0.998)</td>
                </tr>
                <tr>
                    <td>With Neutropenia</td>
                    <td>68</td>
                    <td>34</td>
                    <td>0.941 (0.857-0.997)</td>
                </tr>
                <tr>
                    <td>Without Neutropenia</td>
                    <td>81</td>
                    <td>47</td>
                    <td>0.937 (0.882-0.983)</td>
                </tr>
            </table>

            <div class="caution-box">
                <strong>⚠️ Interpretation Note:</strong> Subgroup analyses should be interpreted with caution due to:
                (1) small sample sizes, (2) use of the same out-of-fold predictions as the main model rather than
                independent validation, and (3) wide confidence intervals. Formal interaction testing was not performed.
            </div>

            <h3>3.7 Learning Curve</h3>

            <div class="figure-container">
                <img src="figures/fig_learning_curve.png" alt="Learning Curve">
                <p class="figure-caption"><strong>Figure 5.</strong> Learning curve showing model performance vs.
                    training set size.</p>
            </div>
        </section>

        <section>
            <h2>4. Discussion</h2>

            <h3>4.1 Principal Findings</h3>
            <p>We developed a machine learning model achieving AUROC 0.934 for predicting ICU admission. Critically,
                even when excluding hypotension (a near-deterministic ICU trigger per clinical protocol), the model
                achieved AUROC 0.887, demonstrating genuine predictive value from other clinical features.</p>

            <h3>4.2 Clinical Implications</h3>
            <p>The model is most useful for patients in the "intermediate risk" category—those without obvious ICU-level
                decompensation but with elevated risk based on other features like qSOFA, metastatic status, and
                comorbidities.</p>

            <h3>4.3 Limitations</h3>
            <ol>
                <li><strong>Sample size (n=149):</strong> Limited power for subgroup analyses</li>
                <li><strong>Single-center data:</strong> External validation essential before deployment</li>
                <li><strong>Retrospective design:</strong> Prospective validation needed</li>
                <li><strong>Hypotension dominance:</strong> The full model's high AUROC is partially driven by the
                    hypotension-ICU protocol; the no-hypotension model (AUROC 0.887) represents more generalizable
                    predictive performance</li>
            </ol>
        </section>

        <section>
            <h2>5. Conclusions</h2>
            <div class="highlight-box">
                <p>A machine learning model incorporating routinely available clinical features can accurately predict
                    ICU admission in febrile oncology patients. The model significantly outperforms established clinical
                    scores. <strong>Importantly, sensitivity analysis excluding hypotension confirms clinically useful
                        discrimination (AUROC 0.887) from other features</strong>, demonstrating value beyond obvious
                    clinical protocols. Prospective external validation is required before clinical implementation.</p>
            </div>
        </section>

        <section class="references">
            <h2>References</h2>

            <h3>Primary References</h3>
            <ol>
                <li>Klastersky J, Paesmans M, Rubenstein EB, et al. The Multinational Association for Supportive Care in
                    Cancer risk index: A multinational scoring system for identifying low-risk febrile neutropenic
                    cancer patients. <em>J Clin Oncol</em>. 2000;18(16):3038-3051.</li>
                <li>Kuderer NM, Dale DC, Crawford J, Cosler LE, Lyman GH. Mortality, morbidity, and cost associated with
                    febrile neutropenia in adult cancer patients. <em>Cancer</em>. 2006;106(10):2258-2266.</li>
                <li>Young MP, Gooder VJ, McBride K, James B, Fisher ES. Inpatient transfers to the intensive care unit:
                    delays are associated with increased mortality and morbidity. <em>J Gen Intern Med</em>.
                    2003;18(2):77-83.</li>
                <li>Teh BW, Harrison SJ, Allison CC, et al. Risk stratification of fever and neutropenia episodes in
                    hematology−oncology patients. <em>Support Care Cancer</em>. 2018;26(11):3725-3732.</li>
                <li>Klastersky J, Paesmans M. The Multinational Association for Supportive Care in Cancer (MASCC) risk
                    index score: 10 years of use for identifying low-risk febrile neutropenic cancer patients.
                    <em>Support Care Cancer</em>. 2013;21(5):1487-1495.
                </li>
                <li>Seymour CW, Liu VX, Iwashyna TJ, et al. Assessment of clinical criteria for sepsis: For the Third
                    International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). <em>JAMA</em>.
                    2016;315(8):762-774.</li>
                <li>Kaukonen KM, Bailey M, Suzuki S, Pilcher D, Bellomo R. Mortality related to severe sepsis and septic
                    shock among critically ill patients in Australia and New Zealand, 2000-2012. <em>JAMA</em>.
                    2014;311(13):1308-1316.</li>
                <li>Rajkomar A, Dean J, Kohane I. Machine learning in medicine. <em>N Engl J Med</em>.
                    2019;380(14):1347-1358.</li>
                <li>Chen T, Guestrin C. XGBoost: A Scalable Tree Boosting System. In: Proceedings of the 22nd ACM SIGKDD
                    International Conference on Knowledge Discovery and Data Mining. San Francisco, CA: ACM;
                    2016:785-794.</li>
                <li>Vickers AJ, Elkin EB. Decision curve analysis: a novel method for evaluating prediction models.
                    <em>Med Decis Making</em>. 2006;26(6):565-574.
                </li>
            </ol>

            <h3>Data Science & Ethics References</h3>
            <ol start="11">
                <li>Collins GS, Reitsma JB, Altman DG, Moons KGM. Transparent Reporting of a multivariable prediction
                    model for Individual Prognosis or Diagnosis (TRIPOD): The TRIPOD Statement. <em>Ann Intern Med</em>.
                    2015;162(1):55-63.</li>
                <li>Wiens J, Saria S, Sendak M, et al. Do no harm: a roadmap for responsible machine learning for health
                    care. <em>Nat Med</em>. 2019;25(9):1337-1340.</li>
                <li>Office for Human Research Protections. Human Subject Regulations Decision Charts. HHS.gov. Available
                    at: https://www.hhs.gov/ohrp/regulations-and-policy/decision-charts/</li>
            </ol>

            <h3>Software References</h3>
            <ol start="14">
                <li>Pedregosa F, Varoquaux G, Gramfort A, et al. Scikit-learn: Machine Learning in Python.
                    <em>JMLR</em>. 2011;12:2825-2830.
                </li>
                <li>Lundberg SM, Lee SI. A Unified Approach to Interpreting Model Predictions. In: Advances in Neural
                    Information Processing Systems 30. 2017.</li>
            </ol>
        </section>

    </div>
</body>

</html>